Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC δ signal transduction

Baek WK, Park JW, Lim JH, Suh SI, Suh MH and Kwon TK . (2002). Gene, 295, 117–123.

Banerjee S, Bueso-Ramos C and Aggarwal BB . (2002). Cancer Res., 62, 4945–4954.

Bernhard EJ, Gruber SB and Muschel RJ . (1994). Proc. Natl. Acad. Sci. USA, 91, 4293–4297.

Brew K, Dinakarpandian D and Nagase H . (2000). Biochim. Biophys. Acta, 1477, 267–283.

Chambers AF and Matrisian LM . (1997). J. Natl. Cancer Inst., 89, 1260–1270.

Cirillo G, Casalino L, Vallone D, Caracciolo A, De Cesare D and Verde P . (1999). Mol. Cell. Biol., 19, 6240–6252.

Fauconneau B, Waffo-Teguo P, Huguet F, Barrier L, Decendit A and Merillon JM . (1997). Life Sci., 61, 2103–2110.

Fremont L . (2000). Life Sci., 66, 6663–6673.

Godichaud S, Krisa S, Couronne B, Dubuisson L, Merillon JM, Desmouliere A and Rosenbaum J . (2000). Hepatology, 31, 922–931.

Gum R, Wang H, Lengyel E, Juarez J and Boyd D . (1997). Oncogene, 14, 1481–1493.

Gupta S, Campbell D, Derijard B and Davis RJ . (1995). Science, 267, 389–393.

Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Kleiner DE and Stetler-Stevenson WG . (1999). Cancer Chemother. Pharmacol., 43 (Suppl), S42–S51.

Lee PP, Hwang JJ, Murphy G and Ip MM . (2000). Endocrinology, 141, 3764–3773.

Minden A, Lin A, McMahon M, Lange-Carter C, Derijard B, Davis RJ, Johnson GL and Karin M . (1994a). Science, 266, 1719–1723.

Minden A, Lin A, Smeal T, Derijard B, Cobb M, Davis R and Karin M . (1994b). Mol. Cell. Biol., 14, 6683–6688.

Nagase H and Woessner Jr JF . (1999). J. Biol. Chem., 274, 21491–21494.

O'Hagan RC, Tozer RG, Symons M, McCormick F and Hassell JA . (1996). Oncogene, 13, 1323–1333.

Overall CM, Wrana JL and Sodek J . (1989). J. Biol. Chem., 264, 1860–1869.

Pace-Asciak CR, Rounova O, Hahn SE, Diamandis EP and Goldberg DM . (1996). Clin. Chim. Acta, 246, 163–182.

Sato H, Kita M and Seiki M . (1993). J. Biol. Chem., 268, 23460–23468.

Sato H and Seiki M . (1993). Oncogene, 8, 395–405.

Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E and Seiki M . (1994). Nature, 370, 61–65.

Simon C, Goepfert H and Boyd D . (1998). Cancer Res., 58, 1135–1139.

Soleas GJ, Diamandis EP and Goldberg DM . (1997a). J. Clin. Lab. Anal., 11, 287–313.

Soleas GJ, Diamandis EP and Goldberg DM . (1997b). Clin. Biochem., 30, 91–113.

Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA and Goldberg GI . (1995). J. Biol. Chem., 270, 5331–5338.

Uddin S, Sassano A, Deb DK, Verma A, Majchrzak B, Rahman A, Malik AB, Fish EN and Platanias LC . (2002). J. Biol. Chem., 277, 14408–14416.

Waas ET, Lomme RM, DeGroot J, Wobbes T and Hendriks T . (2002). Br. J. Cancer, 86, 1876–1883.

Woodhouse EC, Chuaqui RF and Liotta LA . (1997). Cancer, 80, 1529–1537.

Zucker S, Lysik RM, Zarrabi MH and Moll U . (1993). Cancer Res., 53, 140–146.